FDA OKs expanded label for Abiomed's Impella heart pump

|About: ABIOMED, Inc. (ABMD)|By:, SA News Editor

The FDA approves the use of Abiomed's (ABMD -3.6%) Impella 5.0 and Impella LD heart pumps for the treatment of cardiogenic shock for up to 14 days (from six days), a condition in which the heart cannot pump enough blood to support the body's functions. It is most commonly associated with a severe heart attack.

Subscribe for full text news in your inbox